Scientists Have Discovered A New Method Of Detecting Cancer.
A rejuvenated proof marketed as an selection to a mammogram for knocker cancer detection is not an compelling screening TOOL, US health officials say. With the nipple aspirate test, a mamma push collects fluid from a woman's nipple. The unformed is then examined for jargon exceptional and potentially cancerous cells startvigrx.com. The prove is advertised as easier, more comfortable and less painful than mammograms.
However, there is no verification to support claims that the test can find breast cancer, said Dr David Lerner, a medical policewoman at the US Food and Drug Administration and a boob imaging specialist where to buy the medication anti aging treatment. "FDA's be pertinent is that the nipple aspirate probe is being touted as a standalone tool to screen for and determine breast cancer as an alternative to mammography," Lerner said in an means news release.
So "Our horror is that women will forgo a mammogram and have this examination instead". Skipping a mammogram could put a woman's condition and life at risk if breast cancer goes undetected, Lerner warned. He said there is no thorough token that the nipple aspirate test, when second-hand on its own, is an effective screening tool for heart of hearts cancer or any other medical condition.
The test is still being laboured to determine if it might be useful in combination with other methods to shroud for disease. "The bottom line is that women should not rely solely on these nipple aspirate tests for the screening or diagnosis of bust cancer. Mammography is still the gold standard".
In October, 2013, Atossa Genetics pulled its nipple aspirate assay - called the ForeCYTE Breast Health Test - off the peddle after being warned by the FDA that its claims about the try were unsubstantiated. The enterprise claimed the trial was "literally a Pap discredit for soul cancer". Pap smears are a pillar study for cervical cancer.
And Women who have had a nipple aspirate check-up as a form of breast cancer screening should also have a mammogram, according to screening guidelines or as recommended by their doctor. Also, they should palaver to their physician about whether additional tests are needed, the FDA said. One in eight US women will evolve chest cancer in her lifetime provillus.xyz. The plague is the second matchless cancer killer of women in the country.
Комментариев нет:
Отправить комментарий